Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Other Working Capital Changes (2022 - 2026)

Atara Biotherapeutics filings provide 5 years of Other Working Capital Changes readings, the most recent being -$285000.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes fell 3462.5% to -$285000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$276000.0, a 922.22% decrease, with the full-year FY2025 number at $1000.0, up 100.22% from a year prior.
  • Other Working Capital Changes hit -$285000.0 in Q1 2026 for Atara Biotherapeutics, down from $9000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $7.6 million in Q4 2024 to a low of -$13.2 million in Q4 2023.
  • Median Other Working Capital Changes over the past 5 years was -$443000.0 (2024), compared with a mean of -$1.4 million.
  • Biggest five-year swings in Other Working Capital Changes: soared 559.69% in 2023 and later plummeted 3462.5% in 2026.
  • Atara Biotherapeutics' Other Working Capital Changes stood at -$1.2 million in 2022, then plummeted by 972.96% to -$13.2 million in 2023, then skyrocketed by 157.68% to $7.6 million in 2024, then plummeted by 99.88% to $9000.0 in 2025, then tumbled by 3266.67% to -$285000.0 in 2026.
  • The last three reported values for Other Working Capital Changes were -$285000.0 (Q1 2026), $9000.0 (Q2 2025), and -$8000.0 (Q1 2025) per Business Quant data.